once-weekly semaglutide in persons with obesity and knee osteoarthritis GLP-1 drugs like Ozempic Mounjaro may do more than help people lose weight — they could also lower the chances of needing replacement surgery. A new study found that people Once-Weekly Semaglutide in Persons with

DiMarchi, who was a vice president at Eli Lilly and involved in GLP-1 research there, until he left the company in 2003, is that many diseases may share the same root causes, even though we label them and treat them as distinct: This is an endocrine disease, this is a cardiovascular disease, this is a brain disease. This root-cause theory suggests that a wide range of conditions can be treatable with one drug class, sometimes through pathways in the brain and the immune system

However, Medicare and Medicaid typically dont cover GLP-1 medications for weight loss

An experiment carried out on the hydro-alcoholic leaf extract showed a good activity, with the half maximal effective concentration (EC50) of 38.56 0.10 g/mL (DPPH assay)

doi: 10.4049/jimmunol.168.9.4420 164 ChambersCAKuhnsMSEgenJGAllisonJP

Novel GLP-1 mimetics in diabetes: lixisenatide and albiglutide